UnitedHealth Group Inc (UNH) stock
UNHNYSEHospital & Medical Service PlansFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 12/30
$349.91−39.77 (-10.21%)
Close on Nov 18, 2026Market cap $314.08BP/E 22.5Yield 2.49%
UnitedHealth EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
UnitedHealth's EPS for the twelve months ending Jun 30, 2026 was $15.54, down 32.7% year over year. For fiscal 2025 it was $13.23, down 14.7% from the year before. Over ten years it grew 8.2% a year on average. The highest annual figure on record is $23.86 in fiscal 2023.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.23 | -14.7% |
| FY2024 | Dec 31, 2024 | $15.51 | -35.0% |
| FY2023 | Dec 31, 2023 | $23.86 | +12.7% |
| FY2022 | Dec 31, 2022 | $21.18 | +17.1% |
| FY2021 | Dec 31, 2021 | $18.08 | +12.8% |
| FY2020 | Dec 31, 2020 | $16.03 | +11.9% |
| FY2019 | Dec 31, 2019 | $14.33 | +17.6% |
| FY2018 | Dec 31, 2018 | $12.19 | +13.7% |
| FY2017 | Dec 31, 2017 | $10.72 | +47.9% |
| FY2016 | Dec 31, 2016 | $7.25 | +20.6% |
| FY2015 | Dec 31, 2015 | $6.01 | +5.4% |
| FY2014 | Dec 31, 2014 | $5.70 | +3.6% |
| FY2013 | Dec 31, 2013 | $5.50 | +4.2% |
| FY2012 | Dec 31, 2012 | $5.28 | +11.6% |
| FY2011 | Dec 31, 2011 | $4.73 | +15.4% |
| FY2010 | Dec 31, 2010 | $4.10 | +26.5% |
| FY2009 | Dec 31, 2009 | $3.24 | +35.0% |
| FY2008 | Dec 31, 2008 | $2.40 | -29.8% |
| FY2007 | Dec 31, 2007 | $3.42 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $6.04 | +61.5% |
| Q1 FY2026 | Mar 31, 2026 | $6.90 | +0.7% |
| Q4 FY2025 | Dec 31, 2025 | $0.01 | -99.8% |
| Q3 FY2025 | Sep 30, 2025 | $2.59 | -60.2% |
| Q2 FY2025 | Jun 30, 2025 | $3.74 | -17.6% |
| Q1 FY2025 | Mar 31, 2025 | $6.85 | – |
| Q4 FY2024 | Dec 31, 2024 | $5.99 | +2.4% |
| Q3 FY2024 | Sep 30, 2024 | $6.51 | +4.3% |
| Q2 FY2024 | Jun 30, 2024 | $4.54 | -22.0% |
| Q1 FY2024 | Mar 31, 2024 | -$1.53 | -125.7% |
| Q4 FY2023 | Dec 31, 2023 | $5.85 | +16.3% |
| Q3 FY2023 | Sep 30, 2023 | $6.24 | +12.4% |
| Q2 FY2023 | Jun 30, 2023 | $5.82 | +9.0% |
| Q1 FY2023 | Mar 31, 2023 | $5.95 | +12.9% |
| Q4 FY2022 | Dec 31, 2022 | $5.03 | +18.1% |
| Q3 FY2022 | Sep 30, 2022 | $5.55 | +29.7% |
| Q2 FY2022 | Jun 30, 2022 | $5.34 | +19.7% |
| Q1 FY2022 | Mar 31, 2022 | $5.27 | +3.7% |
| Q4 FY2021 | Dec 31, 2021 | $4.26 | +85.2% |
| Q3 FY2021 | Sep 30, 2021 | $4.28 | +29.7% |
| Q2 FY2021 | Jun 30, 2021 | $4.46 | -35.5% |
| Q1 FY2021 | Mar 31, 2021 | $5.08 | +44.3% |
| Q4 FY2020 | Dec 31, 2020 | $2.30 | -37.5% |
| Q3 FY2020 | Sep 30, 2020 | $3.30 | -10.1% |
| Q2 FY2020 | Jun 30, 2020 | $6.91 | +102.0% |
| Q1 FY2020 | Mar 31, 2020 | $3.52 | -1.1% |
| Q4 FY2019 | Dec 31, 2019 | $3.68 | +18.7% |
| Q3 FY2019 | Sep 30, 2019 | $3.67 | +13.3% |
| Q2 FY2019 | Jun 30, 2019 | $3.42 | +14.8% |
| Q1 FY2019 | Mar 31, 2019 | $3.56 | +24.0% |
| Q4 FY2018 | Dec 31, 2018 | $3.10 | -15.1% |
| Q3 FY2018 | Sep 30, 2018 | $3.24 | +29.1% |
| Q2 FY2018 | Jun 30, 2018 | $2.98 | +28.4% |
| Q1 FY2018 | Mar 31, 2018 | $2.87 | +28.7% |
| Q4 FY2017 | Dec 31, 2017 | $3.65 | +109.8% |
| Q3 FY2017 | Sep 30, 2017 | $2.51 | +23.6% |
| Q2 FY2017 | Jun 30, 2017 | $2.32 | – |
| Q1 FY2017 | Mar 31, 2017 | $2.23 | – |
| Q4 FY2016 | Dec 31, 2016 | $1.74 | – |
| Q3 FY2016 | Sep 30, 2016 | $2.03 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?